CancerX Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us harness the full power of innovation to achieve the goals of the Cancer Moonshot.
Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.
Members also include the National Cancer Institute
Steering Committee
CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.
David Fredrickson, Executive Vice President, Oncology Business, AstraZeneca
Rasu Shrestha, Chief Innovation & Commercialization Officer, Atrium Health
Ben Moscovitch, Healthcare and Life Science Public Policy Lead, Americas, Amazon Web Services (AWS)
Sally Werner, Chief Experience Officer, Cancer Support Community
Mary Tolikas, Senior Vice President and Chief Innovation Officer, Dana-Farber Cancer Institute
Omid Toloui, Vice President, Innovation, Elevance Health
Ted Gaubert, Chief Technology Officer, Graphite Health
Najat Khan, Chief Data Science Officer and Global Head, Strategy, Portfolio & Operations, R&D, Janssen Pharmaceutical Companies of Johnson & Johnson
Andrea Downing, Chief Executive Officer, Light Collective
Cait Brumme, Chief Executive Officer, MassChallenge
Kate Wallis, Vice President of Clinical Innovation, Point32Health
Matt Bettonville, Investor, Yosemite
Stay in the Loop
Be the first to know when these resources launch.
